Pharma Journalist -

SMi Reports: Speaker interview from AstraZeneca released ahead of SMi’s 5th Annual 3D Cell Culture taking place on 10 – 11 February 2021 as a virtual conference with online access only.…
Read More...

Novartis announced that the U.S. Food and Drug Administration (FDA) granted iptacopan (LNP023) Breakthrough Therapy Designation (BTD) in paroxysmal nocturnal hemoglobinuria (PNH) and…
Read More...

Genosity, Inc, a biotechnology company offering novel software and laboratory solutions to enable development and deployment of complex NGS assays, announced an agreement with Gemini…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 12 to 1 that the data presented support the use of…
Read More...

M.S.Q. Ventures is pleased to announce that its client, ADC Therapeutics SA, has successfully entered into an agreement to jointly form a new company, Overland ADCT BioPharma (CY)…
Read More...

vTv Therapeutics Inc. announced that vTv Therapeutics LLC (“vTv”) has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2…
Read More...

Salesforce, the global leader in CRM, and Gavi, the Vaccine Alliance, announced that they will collaborate to help Gavi manage critical information to equitably distribute approximately…
Read More...

Eli Lilly and Company and Prevail Therapeutics Inc. announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share in cash (or an aggregate of approximately $880…
Read More...

Novartis announced positive findings from the first interpretable results of the Phase III KESTREL study, assessing the efficacy and safety of Beovu (brolucizumab) 3 mg and 6 mg in…
Read More...

FSD Pharma Inc. announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) for the treatment of…
Read More...